Cargando…

MMP7 cleaves remyelination‐impairing fibronectin aggregates and its expression is reduced in chronic multiple sclerosis lesions

Upon demyelination, transient expression of fibronectin precedes successful remyelination. However, in chronic demyelination observed in multiple sclerosis (MS), aggregates of fibronectin persist and contribute to remyelination failure. Accordingly, removing fibronectin (aggregates) would constitute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Peng, Gorter, Rianne P., de Jonge, Jenny C., Nazmuddin, Muhammad, Zhao, Chao, Amor, Sandra, Hoekstra, Dick, Baron, Wia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099312/ https://www.ncbi.nlm.nih.gov/pubmed/29600597 http://dx.doi.org/10.1002/glia.23328

Ejemplares similares

Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
por: van Schaik, Pauline E. M., et al.
Publicado: (2022)

The EIIIA domain from astrocyte‐derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination
por: Stoffels, Josephine M. J., et al.
Publicado: (2014)

TLR3 agonists induce fibronectin aggregation by activated astrocytes: a role of pro-inflammatory cytokines and fibronectin splice variants
por: Werkman, Inge, et al.
Publicado: (2020)

Macroglial diversity: white and grey areas and relevance to remyelination
por: Werkman, Inge L., et al.
Publicado: (2020)

MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains
por: Bijlard, Marjolein, et al.
Publicado: (2016)

Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages
por: Sikkema, Arend H., et al.
Publicado: (2018)

Astrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelination
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2017)

The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix
por: Ozgen, Hande, et al.
Publicado: (2014)

Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007)

Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination
por: Lentferink, Dennis H., et al.
Publicado: (2018)

Oligodendroglial membrane dynamics in relation to myelin biogenesis
por: Ozgen, Hande, et al.
Publicado: (2016)

Remyelination varies between and within lesions in multiple sclerosis following bexarotene
por: Brown, J. William L., et al.
Publicado: (2022)

7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
por: Kolb, Hadar, et al.
Publicado: (2021)

A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis
por: Rahmanzadeh, Reza, et al.
Publicado: (2022)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019)

Impairing committed cholesterol biosynthesis in white matter astrocytes, but not grey matter astrocytes, enhances in vitro myelination
por: Werkman, Inge L., et al.
Publicado: (2020)

Lesion stage-dependent causes for impaired remyelination in MS
por: Heß, Katharina, et al.
Publicado: (2020)

Human Endogenous Retrovirus Type W Envelope from Multiple Sclerosis Demyelinating Lesions Shows Unique Solubility and Antigenic Characteristics
por: Charvet, Benjamin, et al.
Publicado: (2021)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
por: Podbielska, Maria, et al.
Publicado: (2013)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Jolanda Münzel, E., et al.
Publicado: (2013)

Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
por: Leo, Heinig, et al.
Publicado: (2022)

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)

Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
por: Mohan, Hema, et al.
Publicado: (2014)

Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis
por: Brown, Robert A., et al.
Publicado: (2014)

Erratum to: Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Münzel, E. Jolanda, et al.
Publicado: (2013)

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
por: Bodini, Benedetta, et al.
Publicado: (2016)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures
por: Espitia Pinzón, Nathaly, et al.
Publicado: (2017)

Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions.
por: Natali, P. G., et al.
Publicado: (1995)

MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2012)

A novel biomarker of MMP-cleaved prolargin is elevated in patients with psoriatic arthritis
por: Sinkeviciute, Dovile, et al.
Publicado: (2020)

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
por: Al Nimer, Faiez, et al.
Publicado: (2016)

Correlated Heterospectral Lipidomics for Biomolecular Profiling of Remyelination in Multiple Sclerosis
por: Bergholt, Mads S., et al.
Publicado: (2017)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9rqm4ejtvh611l7djde3829g9e